Yoshitaka Furuto, Daiki Yoshino, Akio Namikawa, Dai Sato, Yuko Shibuya. Eldecalcitol in older adults with kidney vulnerability: a narrative review of risk-based use, dose adjustment, and monitoring. // Clinical and Experimental Nephrology. – 2026. – DOI: 10.1007/s10157-026-02930-w. – URL: https://doi.org/10.1007/s10157-026-02930-w
Yoshitaka Furuto, Daiki Yoshino, Akio Namikawa, Dai Sato, & Yuko Shibuya (2026). Eldecalcitol in older adults with kidney vulnerability: a narrative review of risk-based use, dose adjustment, and monitoring. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-026-02930-w
Yoshitaka Furuto, et al. “Eldecalcitol in older adults with kidney vulnerability: a narrative review of risk-based use, dose adjustment, and monitoring.” Clinical and Experimental Nephrology, 2026. doi:10.1007/s10157-026-02930-w.
@article{Furuto2026,
title = {Eldecalcitol in older adults with kidney vulnerability: a narrative review of risk-based use, dose adjustment, and monitoring},
author = {Furuto, Yoshitaka and Yoshino, Daiki and Namikawa, Akio and Sato, Dai and Shibuya, Yuko},
journal = {Clinical and Experimental Nephrology},
year = {2026},
doi = {10.1007/s10157-026-02930-w},
url = {https://doi.org/10.1007/s10157-026-02930-w}
}